Olli Mikael Carpen

Person

Latest publications

  1. A Functional Homologous Recombination Assay Predicts Primary Chemotherapy Response and Long-Term Survival in Ovarian Cancer Patients

    Tumiati, M., Hietanen, S., Hynninen, J., Pietilä, E., Färkkilä, A., Kaipio, K., Roering, P., Huhtinen, K., Alkodsi, A., Li, Y., Lehtonen, R., Erkan, E. P., Tuominen, M. M., Lehti, K., Hautaniemi, S. K., Vähärautio, A., Grenman, S., Carpen, O. & Kauppi, L., 15 Sep 2018, In : Clinical Cancer Research. 24, 18, p. 4482-4493 12 p.

    Research output: Contribution to journalArticleScientificpeer-review

  2. Identifying differentially methylated sites in samples with varying tumor purity

    Häkkinen, A., Alkodsi, A., Facciotto, C., Zhang, K., Kaipio, K., Leppa, S., Carpen, O., Grenman, S., Hynninen, J., Hietanen, S., Lehtonen, R. & Hautaniemi, S., 15 Sep 2018, In : Bioinformatics. 34, 18, p. 3078-3085 8 p.

    Research output: Contribution to journalArticleScientificpeer-review

  3. Mathematical Modeling Predicts Response to Chemotherapy and Drug Combinations in Ovarian Cancer

    Kozlowska, E., Färkkilä, A., Vallius, T., Carpen, O., Kemppainen, J., Grenman, S., Lehtonen, R., Hynninen, J., Hietanen, S. & Hautaniemi, S., 15 Jul 2018, In : Cancer Research. 78, 14, p. 4036-4044 9 p.

    Research output: Contribution to journalArticleScientificpeer-review

View all (76) »

ID: 116152